Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 


## **Trustees’ Annual Report for the period** 

**From 01/01/2024 Period start date   To** 

**31/12/2024 Period end date** 

**Charity name: Wealthtime Foundation** 

## **Charity registration number: 1176128** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|(1) Such exclusive charitable objects and<br>purposes, for the public benefit, in any<br>part of the world as the charity trustees<br>may in their discretion think fit.<br>(2) Nothing in this constitution shall<br>authorise an application of the property<br>of the CIO for the purposes which are<br>not charitable in accordance with<br>section 7 of the Charities and Trustee<br>Investment (Scotland) Act 2005 and<br>section 2 of the Charities Act (Northern<br>Ireland) 2008.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|The Wealthtime Foundation was<br>established to support projects and<br>initiatives for the benefit of people in and<br>around the city of Bath, and other parts of<br>the UK at the discretion of the trustees<br>including London and Salisbury. The<br>charity does so by raising funds through<br>fundraising activities and the receipt of<br>donations which it in turn uses to provide<br>grants to local charities and initiatives that<br>align with its objects and specifically<br>focuses on helping those it supports to<br>‘pursue their potential together’ (its<br>‘Purpose’).|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|All trustees are aware of the charity’s<br>objects and the need for them to exercise<br>their powers for and with regard to the<br>public benefit.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

SORP reference Para 1.38 Policy on grant making 



Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other 

## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|The Wealthtime Foundation continued to<br>support smaller charities and charitable<br>causes throughout the reporting period in<br>Bath, London and the South West and<br>raise funds for its grant making activities.|



**Additional information (optional)** You may choose to include further statements where relevant about: 

Achievements against Para 1.41 objectives set Performance of fundraising activities against objectives Para 1.41 set Para 1.41 



Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

Investment performance against objectives Other 



Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|The Wealthtime Foundation received<br>£17,739 during the reporting period and<br>spent £8,205 on charitable activities. The<br>charity had cash funds of £22,208 at the<br>end of the reporting period.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|The Wealthtime Foundation seeks to<br>distribute all monies it has raised through<br>fundraising events and charitable donations<br>and the cash still held in reserve at the end<br>of the reporting period was a result of<br>timing and trustee changes rather than a<br>deliberate accumulation of reserves.|
|Amount of reserves held|Para 1.22|£22,208 held in the Wealthtime<br>Foundation’s bank account at the end of<br>the reporting period for the reason stated<br>above.|
|Reasons for holding zero<br>reserves|Para 1.22|N/A|
|Details of fund materially in<br>deficit|Para 1.24|N/A|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|N/A|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47|Fundraising and donations made by the<br>staff of Novia Financial plc (t/a Wealthtime)<br>and Wealthtime Ltd and the wider public<br>more generally.|
|---|---|---|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|A description of the principal<br>risks facing the charity|Para 1.46||
|Other|||





Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|Constitution|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Appointment by the board of trustees,<br>typically following an interview/ expression<br>of interest in joining the charity.|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51|Provision of the charity’s CIO and annual<br>report and accounts in accordance with the<br>charity’s constitution.|
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51|The charity’s board of trustees strives now<br>to meet monthly as per its latest terms of<br>reference and is committed to distributing<br>more of the amounts held in reserves to<br>charitable causes by the year end.<br>Meetings of the charity are organised by<br>the board’s chair and minutes and records<br>of these meetings are kept and stored at<br>the charity’s principal address.|
|Relationship with any<br>related parties|Para 1.51||
|Other|||



## **Reference and Administrative details** 

|Charity name|Wealthtime Foundation|
|---|---|
|Other name the charity uses||
|Registered charity number|1176128|
|Charity’s principal address|Cambridge House<br>Henry Street<br>Bath<br>BA1 1EB|
|||





Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee(if any)**|
|---|---|---|---|---|
||Nicholas James<br>French|Chair|From 11/12/2024|The Wealthtime Foundation<br>board of trustees|
||Joanne Elizabeth<br>Benson||From 06/10/2023|The Wealthtime Foundation<br>board of trustees|
||Martin Jackson||From 12/12/2023|The Wealthtime Foundation<br>board of trustees|
||Shona Rose<br>McCluskey||From 11/12/2024|The Wealthtime Foundation<br>board of trustees|
||Emma Dando||From 10/06/2025|The Wealthtime Foundation<br>board of trustees|
||Rebekah Aimee<br>Bevan||From 10/06/2025|The Wealthtime Foundation<br>board of trustees|
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



## – Corporate trustees names of the directors at the date the report was approved 

**Director name** N/A 

Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|N/A|||





Docusign EnvelopÈ ID." AF5599B2-C62F4D3F-BDSE-D916A3B7773E

Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

## **Funds held as custodian trustees on behalf of others** 

Description of the assets N/A held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Additional information (optional)**<br>**Names and addresses of advisers (Optional information)**|**Additional information (optional)**<br>**Names and addresses of advisers (Optional information)**|**Additional information (optional)**<br>**Names and addresses of advisers (Optional information)**|
|---|---|---|
|**Type of**<br>**adviser**<br>**Name**<br>**Address**|||
||||
||||
||||
||||
|**Name of chief executive or names of senior staff members (Optional information)**|||
||||



## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

N/A 

## **Other optional information** 



Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s)**<br>**Full name(s)**<br>**Position (eg Secretary,**<br>**Chair, etc)**<br>**Date**|||
|---|---|---|
||Nick French|Martin Jackson|
||<br>Trustee (Chair)|Trustee|
||<br>31/10/2025||
||<br>31/10/2025||





Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

|**Wealthtime Foundation**|**Wealthtime Foundation**||**1176128**||
|---|---|---|---|---|
|**Receipts and payments accounts**||||**CC16a**|
|**For the period**<br>**from**|01/01/2024|**To**|31/12/2024||




|**Section A Receipts and payments**|**Section A Receipts and payments**||||||
|---|---|---|---|---|---|---|
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**17,739**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> <br>**17,739**<br>**-**<br>**-**<br> <br>**-**<br>**17,739**<br>**8,205**<br>**80**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**8,285**<br>**-**<br>**-**<br>**-**<br>**8,285**<br>**9,454**<br>**-**<br>**12,754**<br>**22,208**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**17,739**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**17,739**<br>**-**<br>**-**<br>**-**<br>**17,739**<br>**8,205**<br>**80**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**8,285**<br>**-**<br>**-**<br>**-**<br>**8,285**<br> <br>**9,454**||**Last year**<br>**to the nearest £**|
|Fundraising|**17,739**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|<br>**17,739**||||||
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|<br>**-**|||||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
|||||||**-**|
||||||||
|<br>Charitable activities|**8,205**|||||**-**|
|Bank charges|**80**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**|**8,285**|||||**-**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_**|**-**|||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
|||||||**-**|
||||||||
||**9,454**|**-**|**-**|<br>**9,454**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**12,754**|**-**|**-**|**12,754**||**-**|
||**22,208**|**-**|**-**|<br>**22,208**||**-**|



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>CCXX R1 accounts (SS)|**Details**<br>**_Total cash funds_**<br>Bank account<br>1|**Unrestricted**<br>**funds**<br>**to nearest £**<br>**22,208**<br>**-**<br>**-**<br>**22,208**|**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|---|
|||**22,208**|**-**|**-**|
|||**-**|**-**|**-**|
|||**-**|**-**|**-**|
|||**22,208**|**-**|**-**|





Docusign Envelope ID: AF5599B2-C62F-4D3F-BD5E-D916A3B7773E 

|Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**|**Details**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>**Details**<br>Signature|OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Nick French<br>Martin Jackson|OK|
|---|---|---|---|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||||31/10/2025|
||||31/10/2025|
|||||



CCXX R2 accounts (SS) 

31/10/2025 

2 

